Home
Drugs
Bevacizumab
Clinical Trials

Clinical Trials Related to Bevacizumab

Related studies linked through entity extraction aliases.

A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Status: COMPLETED
Phase: PHASE3

MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer

Status: TERMINATED
Phase: PHASE2

Study of Gemcitabine+Platinum Salt+Bevacizumab Combination for Metastatic Collecting Duct Carcinoma (GETUG-AFU 24)

Status: COMPLETED
Phase: PHASE2

Open Label Continuation Study of TRC105 for Patients Who Have Completed a Prior TRC105 Trial

Status: NO_LONGER_AVAILABLE
Phase: N/A

Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer

Status: COMPLETED
Phase: PHASE1/PHASE2

NovoTTF-100A With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse

Status: WITHDRAWN
Phase: PHASE2

Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma:

Status: COMPLETED
Phase: PHASE1/PHASE2

A Phase II Study of Optune (NovoTTF) in Combination With Bevacizumab (BEV) and Temozolomide (TMZ) in Patients With Newly Diagnosed Unresectable Glioblastoma (GBM)

Status: TERMINATED
Phase: PHASE2

TH-302 in Combination With Bevacizumab for Glioblastoma

Status: COMPLETED
Phase: PHASE2

Folfoxiri Plus Bev Followed by Reintroduction of Folfoxiri Plus Bev at Progression Versus Folfox Plus Bev Followed by Folfiri Plus Bev in mCRC

Status: UNKNOWN
Phase: PHASE3

Pembrolizumab +/- Bevacizumab for Recurrent GBM

Status: COMPLETED
Phase: PHASE2

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Status: COMPLETED
Phase: PHASE2

Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients

Status: UNKNOWN
Phase: PHASE2

Bevacizumab Therapy for Brain Arteriovenous Malformation

Status: COMPLETED
Phase: PHASE1

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Status: COMPLETED
Phase: PHASE1

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Status: COMPLETED
Phase: PHASE2

Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema

Status: COMPLETED
Phase: NA

Activity Study of Bevacizumab With Temozolomide ± Irinotecan for Neuroblastoma in Children

Status: COMPLETED
Phase: PHASE2

Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer

Status: COMPLETED
Phase: PHASE2

SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2